Mazzoni Center Appoints New Executive Medical Officer: Dr. Stacey Trooskin Brings Two Decades of Infectious Disease Expertise to Role

Mazzoni Center, the premier health and wellness center serving Philadelphia’s LGBTQ community and the largest LGBTQ nonprofit in the city, has announced the appointment of a new Executive Medical Officer to lead the Center’s team of providers in service areas including primary medical care, HIV and STI prevention, testing, and treatment, gender-affirming care, and behavioral health.

Dr. Stacey Trooskin, who begins her new role on July 31, 2023, comes to Mazzoni Center with two decades of experience focusing on infectious diseases, including serving as a faculty member at the University of Pennsylvania, Perelman School of Medicine.  Most recently, Dr. Trooskin served as the Chief Medical Officer for Philadelphia FIGHT Community Health Centers, a role that she held from 2020 to early 2023, following four years as FIGHT’s Director of Viral Hepatitis Programs.

“I am thrilled to join the Mazzoni Center team,” says Dr. Trooskin.  “I am looking forward to working with Mazzoni Center's extraordinary staff to support the critical work they do every day and to guide clinical growth to meet the needs of the community."

Dr. Trooskin’s appointment follows a less formal role with Mazzoni Center that began in March of 2023 as an Executive Medical Consultant, with a focus that included providing guidance to the Center’s executive leadership team, facilitating increased clinical productivity, and developing new clinical policies and procedures.

In making the announcement of Dr. Trooskin’s appointment, Mazzoni Center’s President and Executive Officer, Sultan Shakir, said: “When we look at the increasing challenges faced by the LGBTQ community, from bans on trans health care across the country to the shifting landscape of health insurance, it’s clear that Dr. Trooskin’s demonstrated leadership will help ensure that Mazzoni Center continues to evolve to meet the needs of the LGBTQ community by providing high-quality, culturally competent, and community-focused health care.”

An internist with a specialty in infectious diseases, Dr. Trooskin has a strong interest in public health, particularly the epidemiology of hepatitis C, and identifying and overcoming barriers to testing and treatment. She completed a three-year term of service as a member of the American Association for the Study of Liver Diseases and Infectious Disease Society of America's HCV treatment guidance panel and currently serves as the Chief Medical Advisor to the National Viral Hepatitis Roundtable and as the Medical Director for the Health Federation’s HCV technical assistance program called “C Change.” Dr. Trooskin is widely recognized for her activism and advocacy around issues related to access to HCV testing and treatment, particularly for incarcerated individuals and individuals who use drugs.

Dr. Trooskin received her MPH in Public Health from Yale University, her Ph.D. (Epidemiology) from Rutgers School of Public Health, and her MD from the University of Medicine and Dentistry of New Jersey, at the Robert Wood Johnson School of Medicine.